ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis

ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis

The strongest genetic risk factor for sporadic Alzheimer’s disease (AD) is the presence of the ε4 allele of the apolipoprotein E (ApoE) gene, the major apolipoprotein involved in brain cholesterol homeostasis. Being astrocytes the main producers of cholesterol and ApoE in the brain, we investigated...

Full description

Bibliographic Details
Main Authors:	Erica Staurenghi, Valerio Leoni, Marco Lo Iacono, Barbara Sottero, Gabriella Testa, Serena Giannelli, Gabriella Leonarduzzi, Paola Gamba
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Antioxidants
Subjects:	astrocytes alzheimer’s disease apolipoprotein E ApoE4 cholesterol metabolism lipids
Online Access:	https://www.mdpi.com/2076-3921/11/11/2168

Similar Items

Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
by: Erica Staurenghi, et al.
Published: (2021-11-01)

ApoE4 Astrocytes Secrete Basement Membranes Rich in Fibronectin and Poor in Laminin Compared to ApoE3 Astrocytes
by: Abby Keable, et al.
Published: (2020-06-01)

Regulation of astrocyte lipid metabolism and ApoE secretionby the microglial oxysterol, 25-hydroxycholesterol
by: Anil G. Cashikar, et al.
Published: (2023-04-01)

Opposing Effects of ApoE2 and ApoE4 on Glycolytic Metabolism in Neuronal Aging Supports a Warburg Neuroprotective Cascade against Alzheimer’s Disease
by: Xin Zhang, et al.
Published: (2023-01-01)

ApoE gene polymorphisms and metals and their interactions with cognitive function
by: Zeyan Ye, et al.
Published: (2023-08-01)

The Role of ApoE Expression and Variability of Its Glycosylation in Human Reproductive Health in the Light of Current Information
by: Monika Kacperczyk, et al.
Published: (2021-07-01)

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis
by: Thomas E. Mahan, et al.
Published: (2022-02-01)

Microglial APOE4: more is less and less is more
by: Ghazaleh Eskandari-Sedighi, et al.
Published: (2023-12-01)

NGF Modulates Cholesterol Metabolism and Stimulates ApoE Secretion in Glial Cells Conferring Neuroprotection against Oxidative Stress
by: Mayra Colardo, et al.
Published: (2022-04-01)

<i>APOE</i> Molecular Spectrum in a French Cohort with Primary Dyslipidemia
by: Yara Abou Khalil, et al.
Published: (2022-05-01)

From degenerative disease to malignant tumors: Insight to the function of ApoE
by: Ganggang Miao, et al.
Published: (2023-02-01)

Bosnian study of APOE distribution (BOSAD): a comparison with other European populations
by: Grażyna Adler, et al.
Published: (2017-08-01)

PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
by: Bianca Papotti, et al.
Published: (2022-10-01)

APOE genotype and biological sex regulate astroglial interactions with amyloid plaques in Alzheimer’s disease mice
by: T. L. Stephen, et al.
Published: (2022-12-01)

Association of candidate genetic variants and circulating levels of ApoE/ApoJ with common neuroimaging features of cerebral amyloid angiopathy
by: Anna Bonaterra-Pastra, et al.
Published: (2023-04-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

Precision Nutrition for Alzheimer’s Prevention in <i>ApoE4</i> Carriers
by: Nicholas G. Norwitz, et al.
Published: (2021-04-01)

Kefir peptides attenuate atherosclerotic vascular calcification and osteoporosis in atherogenic diet-fed ApoE−/− knockout mice
by: Gary Ro-Lin Chang, et al.
Published: (2023-04-01)

Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
by: Monica Xiong, et al.
Published: (2023-03-01)

Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor <i>APOE</i>
by: Harvey R. Fernandez, et al.
Published: (2020-12-01)

Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
by: Sulev Koks, et al.
Published: (2021-03-01)

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
by: Maria Fe Lanfranco, et al.
Published: (2020-09-01)

Apolipoprotein E (ApoE) orchestrates adipose tissue inflammation and metabolic disorders through NLRP3 inflammasome
by: Yulin Zhang, et al.
Published: (2023-12-01)

No Strong Association between the Apolipoprotein E E4 Allele and Glaucoma
by: Sean Mullany, MD, et al.
Published: (2023-09-01)

Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
by: Na Wang, et al.
Published: (2022-11-01)

Apolipoprotein E (ApoE) ε4 Genotype (ApoE rs429358—ApoE rs7412 Polymorphisms) Is Not Associated with Long COVID Symptoms in Previously Hospitalized COVID-19 Survivors
by: César Fernández-de-las-Peñas, et al.
Published: (2023-07-01)

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
by: Rosalía Fernández-Calle, et al.
Published: (2022-09-01)

Lipolysis-Stimulated Lipoprotein Receptor Acts as Sensor to Regulate ApoE Release in Astrocytes
by: Ameziane Herzine, et al.
Published: (2022-08-01)

Levels of Arachidonic Acid?Derived Oxylipins and Anandamide Are Elevated Among Military APOE ?4 Carriers With a History of Mild Traumatic Brain Injury and Post-Traumatic Stress Disorder Symptoms
by: Aurore Nkiliza, et al.
Published: (2023-09-01)

Relationship between the Presence of the <i>ApoE ε</i>4 Allele and EEG Complexity along the Alzheimer’s Disease Continuum
by: Víctor Gutiérrez-de Pablo, et al.
Published: (2020-07-01)

Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes
by: Masato Komai, et al.
Published: (2024-03-01)

Machine Learning Approach to Identify Case-Control Studies on ApoE Gene Mutations Linked to Alzheimer’s Disease in Italy
by: Giorgia Francesca Saraceno, et al.
Published: (2024-02-01)

A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
by: Ana C. Valencia-Olvera, et al.
Published: (2023-12-01)

Genetic Variation of Apolipoprotein E (ApoE) in Surabaya, Palu and Alor Populations of Indonesia
by: Pramudji Hastuti, et al.
Published: (2011-12-01)

APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
by: E Losonczi, et al.
Published: (2010-11-01)

APOE effects on regional tau in preclinical Alzheimer’s disease
by: Christina B. Young, et al.
Published: (2023-01-01)

Liver-ing in your head rent free: peripheral ApoE4 drives CNS pathology
by: Lesley R. Golden, et al.
Published: (2022-10-01)

ApoE transiently regulates hippocampus amyloid‐beta deposition to stable learning and memory ability in adult rats exposed in sevoflurane
by: Shan Xu, et al.
Published: (2021-06-01)

Apolipoprotein E is a Potential Biomarker for Predicting Cancer Prognosis and is Correlated with Immune Infiltration
by: Chen J, et al.
Published: (2024-03-01)

Association between Apolipoprotein E polymorphism and myocardial infarction risk: A systematic review and meta‐analysis
by: Yi-Lian Wang, et al.
Published: (2015-01-01)